|
Press release
2000 2001 2002 2003 2004 2005 2006
2006
BiMeince in South Korea to distribute The Genetics Company’s beta-Amyloid and Tau Antibodies and ELISA Kits; November 2006
The Genetics Company and i-DNA Genetics, a Singapore-based supplier and distributor, signed agreement for distribution in China, India, South-East Asia, Australia and New Zealand; September 2006
The Genetics Company and Euromedex, a French wholesaler, signed agreement for distribution in France; September 2006
JSW-Research and The Genetics Company renew their long-term supply agreement for Alzheimer diagnostic kits; August 2006
The Genetics Company announces the issuance of two European patents covering fundamental technologies in computational chemistry; August 2006
2005
Morphochem and The Genetics Company announce the successful resolution of the X-ray structure of ß-secretase with a novel inhibitor compound; July 2005
Prodotti Gianni in Italy to distribute The Genetics Company’s Amyloid Beta ELISA Kits and Antibodies; May 2005
The Genetics Company announces the closing of its Series C equity financing round of 25 million CHF with the participation of new and existing investors, February 2005
Top
2004
Alzheimer’s Disease Diagnostics Reference Center and Vocational Training Event with PD Dr. H. Tumani, Prof. Dr. J. Wiltfang and CA Dr. Ficker in Dresden, Germany;
Press Release, November 2004
Funakoshi in Japan to distribute The Genetics Company’s Amyloid Beta ELISA Kits and Antibodies;
Press Release, November 2004
Alzheimer’s Disease Diagnostics Reference Center and Vocational Training Event with Prof. Dr. Beyreuther, Prof. Dr. Wiltfang and Prof. Dr. Hildebrandt in Bremen, Germany; September 2004The Genetics Company and Morphochem enter into collaboration
Press Release, March 31, 2004
The Genetics Company and Morphochem enter into collaboration
Press Release, March 31, 2004
The Genetics Company closes long-term supply agreement with JSW-Research
Press Release, March 22, 2004
Top
2003
The Genetics Company raises CHF 14 M in Series B Financing Round
Press Release, November 14, 2003
The Genetics Company announces positive results of clinical trials for Alzheimer diagnostics test
Press Release, September 24, 2003
The Genetics Company, Inc. Announces Acquisition of Key Assets from Abeta GmbH, Licensing Agreement with Major Pharmaceutical Company, and Execution of Collaboration Agreements with Worldwide Leading Scientists in the Field of Alzheimer’s Disease.
Press Release, June 16, 2003
The Genetics Company announces today the issuance of United States Patent US 6,548,733 B2 covering INVOSCREENTM, a highly versatile highthroughput in vivo drug screening and validation platform in Drosophila.
Press Release, May 15, 2003
The Genetics Company, Inc. Announces Acquisition of
Key Assets from CallistoGen AG, Secures further Financing, Streamlines
R&D Portfolio, and Strengthens Management Team
Press Release, January 22, 2003
Top
2002
The Genetics Company and the University of Zurich, both Switzerland, shed new light on a key cellular mechanism associated with colon cancer
Press Release, April 5, 2002
Top
2001
The Genetics Company, Inc. and Discovery Partners International’s Discovery Technologies Ltd. enter research collaboration
Press Release, August 24, 2001
The Genetics Company, Inc. expands Management Team
Press Release, June 20, 2001
Top
2000
Young Swiss biotech company concludes research collaboration agreement with Intervet
Media Release, December 6, 2000
First financing round for young Swiss biotechnology company successfully concluded
Media Release, July 19, 2000
|
